XML 59 R37.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE (Details) - shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities [1] 31,013 93,892
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities [2] 16,725
Unvested Restricted Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities 202,787 144,211
[1] Shares underlying stock options assumed pursuant to the merger agreement with Precision Healing, Inc. (“Precision Healing”) in April 2022.
[2] Shares underlying warrants assumed pursuant to the merger agreement with Precision Healing in April 2022.